Paul R Morris, MD in Apopka, FL - Pathology

Paul R Morris, MD is a Pathology - Clinical Pathology physician based in Apopka, Florida. Paul R Morris is licensed to practice in Florida (license number ME85699) and his current practice location is 2689 Park Ridge St, Apopka, Florida. He can be reached at his office (for appointments etc.) via phone at (689) 238-8349.

NPI number for Paul R Morris is 1962659938 and his current mailing address is 2689 Park Ridge St, Apopka, Florida. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1962659938.

Contact Information

	Paul R Morris, MD
	2689 Park Ridge St, Apopka, FL 32712-5272
	(689) 238-8349
	Not Available

Physician's Profile

Full Name	Paul R Morris
Gender	Male
Speciality	Pathology - Clinical Pathology
Location	2689 Park Ridge St, Apopka, Florida
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1962659938
Provider Enumeration Date: 08/21/2008
Last Update Date: 06/05/2023

Medical Identifiers

Medical identifiers for Paul R Morris such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1962659938	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZC0006X	Pathology - Clinical Pathology	ME85699 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paul R Morris is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paul R Morris, MD 2689 Park Ridge St, Apopka, FL 32712-5272 Ph: (689) 238-8349	Paul R Morris, MD 2689 Park Ridge St, Apopka, FL 32712-5272 Ph: (689) 238-8349

News Archive

Viral protein is an effective preventative against infection

For parents, eight million cases of acute middle-ear infections every year adds up to a lot of sleepless nights and trips to the pediatrician.

New tactics for repelling, controlling disease-carrying insects

In the battle between insect predators and their prey, chemical signals called kairomones serve as an early-warning system. Pervasively emitted by the predators, the compounds are detected by their prey, and can even trigger adaptations, such a change in body size or armor, that help protect the prey. But as widespread as kairomones are in the insect world, their chemical identity has remained largely unknown. New research by Rockefeller University's Joel E. Cohen and colleagues at the University of Haifa in Israel has identified two compounds emitted by mosquito predators that make the mosquitoes less inclined to lay eggs in pools of water.

L.A. Care Health Plan receives $15.6M federal grant to establish HITEC-LA

L.A. Care Health Plan, the nation's largest public health plan, announced today that the organization has received a $15.6 million federal grant to establish the Health Information Technology Regional Extension Center, called HITEC-LA, that will help doctors in L.A. County adopt and use Electronic Health Records in a meaningful way.

AANMA survey details the impact of asthma and allergies on patients and their families

Today Allergy & Asthma Network Mothers of Asthmatics released a first-of-its-kind survey detailing the impact of asthma and allergies on the people who cope with it every day.

VTE patients tend to die earlier from bladder cancer

In a study of 3879 patients who underwent radical cystectomy to treat bladder cancer, 3.6% were diagnosed with a venous thromboembolism (VTE)—which occurs when a blood clot forms in a vein, potentially breaking loose and traveling to the lung—within 1 month of their surgical admission date.

Paul R Morris, MD - Pathology in Apopka, FL